Bacterial meningitis in children

Sáez-Llorens, Xavier; McCracken, George H.

doi:10.1016/s0140-6736(03)13693-8

Cited by 444 publications

(310 citation statements)

References 102 publications

Supporting

Mentioning

280

Contrasting

Unclassified

Order By: Relevance

“…Unfortunately, bacterial meningitis fatality rates remain high, with reported cases between 2% and 30%, despite emerging antibiotics [12]. Moreover, permanent sequelae such as epilepsy, mental retardation, or sensorineural hearing loss are observed in 10-20% of those who survive [13].…”

Section: Discussionmentioning

confidence: 99%

Meningococcal serogroup W and varicella-zoster virus meningitis in an Irish infant

Maduemem¹,

Vatca²,

Mohammed³

et al. 2018

Int J Case Rep Images

View full text Add to dashboard Cite

International Journal of Case Reports and Images (IJCRI) is an international, peer reviewed, monthly, open access, online journal, publishing high-quality, articles in all areas of basic medical sciences and clinical specialties.Aim of IJCRI is to encourage the publication of new information by providing a platform for reporting of unique, unusual and rare cases which enhance understanding of disease process, its diagnosis, management and clinico-pathologic correlations.

show abstract

Section: Discussionmentioning

confidence: 99%

Meningococcal serogroup W and varicella-zoster virus meningitis in an Irish infant

Maduemem¹,

Vatca²,

Mohammed³

et al. 2018

Int J Case Rep Images

View full text Add to dashboard Cite

show abstract

“…CSF analysis is the primary diagnostic procedure required to make a diagnosis of bacterial meningitis [16,17].…”

Section: Diagnosismentioning

confidence: 99%

Neuro-Intensive Care of Patients with Acute CNS Infections

Beckham

Tyler

2012

Neurotherapeutics

View full text Add to dashboard Cite

Summary Infections in the central nervous system (CNS) are caused by a wide range of microorganisms resulting in distinct clinical syndromes including meningitis, encephalitis, and pyogenic infections, such as empyema and brain abscess. Bacterial and viral infections in the CNS can be rapidly fatal and can result in severe disability in survivors. Appropriate identification and acute management of these infections often occurs in a critical care setting and is vital to improving outcomes in this group of patients. This review of diagnosis and management of acute bacterial and viral infections in the CNS provides a general approach to patients with a suspected CNS infection and also provides a more detailed review of the diagnosis and management of patients with suspected bacterial meningitis, viral encephalitis, brain abscess, and subdural empyema.

show abstract

“…Although vaccination strategies, antibiotic treatment and adequate hospital care can strongly reduce its negative consequences, BM remains the cause of substantial morbidity and mortality both in developing and developed countries (1)(2)(3) .…”

Section: Introductionmentioning

confidence: 99%

Revisão sistemática do uso da dexametasona como terapia adjuvante na meningite bacteriana em crianças

Prats

Gaspar

Ribeiro

et al. 2012

Rev. paul. pediatr.

View full text Add to dashboard Cite

Revisão sistemática do uso da dexametasona como terapia adjuvante na meningite bacteriana em criançasRevisión sistemática del uso de la dexametasona como terapia adyuvante en la meningitis bacteriana en niños João Antonio G. G ABSTRACTObjective: To analyze the best available evidence from the last 15 years on the benefits of adjuvant therapy with dexamethasone for bacterial meningitis in children.Data sources: Randomized controlled trials comparing dexamethasone to placebo and/or other adjuvant therapies in patients with bacterial meningitis diagnosed by biochemical, cytological and/or microbiological data. Studies with patients from 29 days to 18 years of age, from 1996 to 2011, were searched at Medline, Lilacs and SciELO databases. The evaluated outcomes were mortality and development of neurological and/or hearing impairment. Studies related to tuberculous meningitis were excluded.Data synthesis: With the specified criteria, five published studies were identified corresponding to four study protocols. None of the studies showed differences between dexamethasone and placebo for the evaluated outcomes. All analyzed studies had high methodological quality (Jadad et al score=5).Conclusions: Current evidence is insufficient to support routine adjuvant therapy with dexamethasone to reduce mortality, hearing impairment, or neurological sequelae in pediatric patients with non-tuberculous bacterial meningitis.Key-words: meningitis, bacterial; dexamethasone; deafness; mortality. RESUMOObjetivo: Analisar a melhor evidência disponível nos últimos 15 anos com relação aos benefícios da terapia adjuvante com dexametasona na meningite bacteriana em população pediátrica.Fontes de dados: Das bases de dados Medline, Lilacs e SciELO, foram analisados ensaios clínicos randomizados de 1996 a 2011, os quais comparavam a dexametasona ao placebo e/ou a outra terapia adjuvante em pacientes com meningite bacteriana diagnosticada laboratorialmente por critérios quimiocitológicos e/ou bacteriológicos, na faixa etária de 29 dias aos 18 anos. Os desfechos avaliados foram mortalidade e ocorrência de sequelas neurológicas e/ou auditivas. Foram excluídos estudos relacionados à meningite tuberculosa.Síntese dos dados: Com os critérios utilizados, foram identificadas cinco publicações correspondentes a quatro protocolos de estudo. Nenhum dos estudos mostrou diferenças entre a dexametasona e o placebo para os desfechos avaliados. Os estudos analisados tiveram alta qualidade (escore de Jadad et al=5).Conclusões: As evidências encontradas na literatura são insuficientes para indicar de forma rotineira o uso da dexametasona como terapia adjuvante para redução de mortalidade, perda auditiva e sequelas neurológicas em pacientes pediátricos com meningite bacteriana não tuberculosa.Palavras-chave: meningite bacteriana; dexametasona; surdez; mortalidade. João Antonio G. G. Prats et al RESUMEN Objetivo:El presente estudio tiene por objetivo el análisis de la mejor evidencia disponible los últimos 15 años respecto a los beneficios de la terapia adyuvant...

show abstract

Bacterial meningitis in children

Cited by 444 publications

References 102 publications

Meningococcal serogroup W and varicella-zoster virus meningitis in an Irish infant

Meningococcal serogroup W and varicella-zoster virus meningitis in an Irish infant

Neuro-Intensive Care of Patients with Acute CNS Infections

Revisão sistemática do uso da dexametasona como terapia adjuvante na meningite bacteriana em crianças

Contact Info

Product

Resources

About